These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27230588)

  • 1. Epistatic interactions between ancestral genotype and beneficial mutations shape evolvability in Pseudomonas aeruginosa.
    Gifford DR; Toll-Riera M; MacLean RC
    Evolution; 2016 Jul; 70(7):1659-66. PubMed ID: 27230588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa.
    MacLean RC; Perron GG; Gardner A
    Genetics; 2010 Dec; 186(4):1345-54. PubMed ID: 20876562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.
    Hall AR; MacLean RC
    Evolution; 2011 Aug; 65(8):2370-9. PubMed ID: 21790582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
    Qi Q; Preston GM; MacLean RC
    mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.
    Vogwill T; Kojadinovic M; MacLean RC
    Proc Biol Sci; 2016 May; 283(1830):. PubMed ID: 27170722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental variation alters the fitness effects of rifampicin resistance mutations in Pseudomonas aeruginosa.
    Gifford DR; Moss E; MacLean RC
    Evolution; 2016 Mar; 70(3):725-30. PubMed ID: 26880677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of multiple drug resistance in Pseudomonas aeruginosa.
    Ward H; Perron GG; Maclean RC
    J Evol Biol; 2009 May; 22(5):997-1003. PubMed ID: 19298493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.
    Qi Q; Toll-Riera M; Heilbron K; Preston GM; MacLean RC
    Proc Biol Sci; 2016 Jan; 283(1822):. PubMed ID: 26763710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary reversals of antibiotic resistance in experimental populations of Pseudomonas aeruginosa.
    Gifford DR; MacLean RC
    Evolution; 2013 Oct; 67(10):2973-81. PubMed ID: 24094347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant bacteria compensate for the epistasis between resistances.
    Moura de Sousa J; Balbontín R; Durão P; Gordo I
    PLoS Biol; 2017 Apr; 15(4):e2001741. PubMed ID: 28419091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Resistance Evolution Is Contingent on the Quorum-Sensing Response in Pseudomonas aeruginosa.
    Hernando-Amado S; Sanz-García F; Martínez JL
    Mol Biol Evol; 2019 Oct; 36(10):2238-2251. PubMed ID: 31228244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation Through Lifestyle Switching Sculpts the Fitness Landscape of Evolving Populations: Implications for the Selection of Drug-Resistant Bacteria at Low Drug Pressures.
    Matange N; Hegde S; Bodkhe S
    Genetics; 2019 Mar; 211(3):1029-1044. PubMed ID: 30670539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
    Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
    Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative epistasis between beneficial mutations in an evolving bacterial population.
    Khan AI; Dinh DM; Schneider D; Lenski RE; Cooper TF
    Science; 2011 Jun; 332(6034):1193-6. PubMed ID: 21636772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa.
    MacLean RC; Buckling A
    PLoS Genet; 2009 Mar; 5(3):e1000406. PubMed ID: 19266075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of epistasis and pleiotropy on evolutionary adaptation.
    Ostman B; Hintze A; Adami C
    Proc Biol Sci; 2012 Jan; 279(1727):247-56. PubMed ID: 21697174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive genetic variation and evolvability of a multivariate trait can be increased by epistatic gene action.
    Griswold CK
    J Theor Biol; 2015 Dec; 387():241-57. PubMed ID: 26431770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa.
    Hall AR; Griffiths VF; MacLean RC; Colegrave N
    Proc Biol Sci; 2010 Feb; 277(1681):643-50. PubMed ID: 19889704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Here's to the losers: evolvable residents accelerate the evolution of high-fitness invaders.
    Gifford DR; Toll-Riera M; Kojadinovic M; MacLean RC
    Am Nat; 2015 Jul; 186(1):41-9. PubMed ID: 26098337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of selected mutations and genotypic landscapes under Fisher's geometric model.
    Blanquart F; Achaz G; Bataillon T; Tenaillon O
    Evolution; 2014 Dec; 68(12):3537-54. PubMed ID: 25311558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.